期刊文献+

脂氧素受体激动剂BML-111对野百合碱诱导肺动脉高压大鼠肺动脉压力的影响 被引量:1

Effects of Lipoxin Receptor Agonist BML-111 on Pulmonary Arterial Hypertension of Rats Induced by Monocrotaline
下载PDF
导出
摘要 目的:观察脂氧素受体激动剂BML-111对野百合碱(MCT)诱导肺动脉高压大鼠肺动脉压力的影响及其机制。方法:选择SD大鼠30只,随机分为3组:C组、PH组、B组,PH组和B组大鼠行皮下注射野百合碱50μg/g,C组注射等量0.9%氯化钠溶液,自野百合碱注射的当日起,B组每天腹腔注射1 mg.kg-1.d-1BML-111连续4周。实验测量指标:平均肺动脉压力(MPAP)、右心室收缩压(RVSP)、右心室(RV)[左室(LV)+室间隔(S)]、肺组织匀浆炎性因子白介素-8(IL-8)、内皮间粘附分子(ICAM-1)、单核细胞趋化蛋白(MCP-1)的水平。结果:PH组、B组MPAP、RVSP、RV/(LV+S)、IL-8、ICAM-1、MCP-1的水平高于C组(P<0.05);B组MPAP、RVSP、RV/(LV+S)、IL-8、ICAM-1、MCP-1低于PH组(P<0.05)。结论:脂氧素受体激动剂BML-111可减轻野百合碱诱导肺动脉高压大鼠肺动脉压力,其机制可能与减轻肺周围组织炎症反应有关。 Objective To observe the the effects of BML-111 on pulmonary arterial hypertension rats induced by monocrotaline and its possible mechanisms.Methods Thirty SD rats were randomly divided into group C,group PH and group B.The rats in group PH and group B were given subcutaneous injection with monocrotaline at a dose of 50 μg/g,while group C were given normal saline with the same volume.The rats in group B were given intraperitoneal injection with BML-111 at a dose of 1 mg·kg-1 daily for 4 weeks.The levels of MPAP,RVSP,RV/(LV+S),the concentrations of IL-8,ICAM-1,MCP-1 of pulmonary tissues were mearsured.Results The levels of MPAP,RVSP RV/(LV+S) and the concentrations of IL-8,ICAM-1,MCP-1 in group PH and group B were significantly higher than those of group C(P<0.05),meanwhile,the above indexes of group B were significantly higher than those of group PH(P<0.05).Conclusion BML-111 can ameliorate pulmonary arterial hypertension of rats induced by monocrotaline,wihch may relate to its reducing the inflammation of pulmonary tissues.
出处 《湖北医药学院学报》 CAS 2013年第2期146-149,共4页 Journal of Hubei University of Medicine
基金 湖北省十堰市科技局指导项目(ZD20111016)
关键词 脂氧素受体激动剂 野百合碱 肺动脉高压 大鼠 BML-111 Monocrotaline Pulmonary arterial hypertension Rat
  • 相关文献

参考文献2

二级参考文献26

  • 1YongMeng,Qing-YongMa,Xiao-PingKou,JunXu.Effect of resveratrol on activation of nuclear factor kappa-B and inflammatory factors in rat model of acute pancreatitis[J].World Journal of Gastroenterology,2005,11(4):525-528. 被引量:44
  • 2Fredenburgh LE,Perrella MA,Milsialis SA.The role of Heme oxygenase-1 in pulmonary disease[J].Am J Respir Cell Mol Biol, 2007,36(2):158-65.
  • 3Zhou H,Liu H,Porvasnik SL,et al.Heme oxygenase-1 mediates the protective effects of rapamycin in monocrotaline-induced pulmonary hypertension[J].Lab Invest,2006,86(1):62-71.
  • 4Achcar RO,Demura Y,Rai PR,et al.Loss of caveolin and heme oxygenase expression in severe pulmonary hypertension[J].Chest, 2006,129(3):696-705.
  • 5Soares MP,Usheva A,Brouard S,et al.Modulation of endothelial cell apoptosis by heme oxygenase-1-derived carbon monoxide[J]. Antioxid Redox Signal,2002,4(2):321-9.
  • 6Leffler CW,Parfenova H,Jaggar JH.Carbon monoxide as an endogenous vascular modulator[J].Am J Physiol Heart Circ Physiol,2011,301(1):H1-H11.
  • 7Durante W.Targeting heme oxygenase-1 in vascular disease[J]. Curr Drug Targets,2010,11(12):1504-16.
  • 8Liang OD,Mitsialis SA,Chang MS,et al.Mesenchymal stromal cells expressing heme oxygenase-1 reverse pulmonary hypertension [J].Stem Cells,2011,29(1):99-107.
  • 9Sandoval MJ,Cutini PH,Rauschemberger MB,et al.The soyabean isoflavone genistein modulates endothelial cell behaviour[J].Br J Nutr,2010,104(2):171-9.
  • 10Yu JY,Lee JJ,Lim Y,et al.Genistein inhibits rat aortic smooth muscle cell proliferation through the induction of p27kip1[J].J Pharmacol Sci,2008,107(1):90-8.

共引文献10

同被引文献10

  • 1王毅,林伟,施举红.野百合碱处理大鼠肺动脉高压模型的塑造[J].浙江临床医学,2007,9(6):749-750. 被引量:7
  • 2Dorfmuller P, Perros F, Balabanian K, et al. Inflammation in pulmonary arterial hypertension. Eur Respir J, 2003,22(2):358-363.
  • 3Humbert M, Montani D, Perros F, et al. Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension. Vascul Pharmacol, 2008,49 (4- 6): 113-118.
  • 4Ahmadi-Simab K, Gross WL. Pulmonary arterial hypertension in collagenoses: clinical features, epidemiology, pathogenesis, diagnosis and treatment. Z Rheumatol, 2006,65(4):297-300, 302-305.
  • 5Price LC, Wort SJ, Perros F, et al. Inflammation in pulmonary arterial hypertension. Chest, 2012,141(1):210-221.
  • 6Kherbeck N, Tamby MC, Bussone G, et al. The Role of Inflammation and Autoimmunity in the Pathophysiology of Pulmonary Arterial Hypertension. Clin Rev Allergy Immunol, 2013,44(1):31-38.
  • 7Sakao S, Tatsumi K, Voelkel NF. Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation. Respir Res, 2009, 10:95.
  • 8Zhang L, Wan J, Li H, et al. Protective effects ofBML-111, a lipoxin A(4)receptor agonist, on carbon tetrachloride-induced liver injury in mice. Hepatol Res, 2007,37(11):948-956.
  • 9Gong J, Guo S, Li liB, et al. BML-111, a lipoxin receptor agonist, protects haemorrhagic shock-induced acute lung injury in rats. Resuscitation, 2012,83(7):907-912.
  • 10Wang Q, Zuo XR, Wang YY, et al. Monocrotaline-induced pulmonary arterial hypertension is attenuated by TNF-alpha antagonists via the suppression of TNF-alpha expression and NF-kappaB pathway in rats. Vascul Pharmacol, 2013,58(1-2):71-77.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部